CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 10 enrolled
Drug / intervention
Memantinedrug
Likely dose
Memantine 30mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00830375
NCT00830375Phase 2Completed
CompareCT.gov

Memantine Treatment of Compulsive Buying: An Open-Label Study

University of Minnesota·interventional·Posted Jan 27, 2009·Updated Jul 29, 2019

In Brief

A Phase 2 clinical trial evaluating Memantine for Compulsive Buying. Completed, enrolled 10 participants across 2 sites.

Detailed Summary

This is an 8-week, open-labe study of memantine in the treatment of compulsive buying.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCompulsive Buying
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 27, 2009
Enrollment StartDec 1, 2008
Primary CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 17.4 years ago

Interventions

Memantinedrug

10-30mg, by mouth, daily